Attached files
| file | filename |
|---|---|
| EX-10.2 - EX-10.2 - Tobira Therapeutics, Inc. | tbra-ex102_550.htm |
| EX-32.1 - EX-32.1 - Tobira Therapeutics, Inc. | tbra-ex321_7.htm |
| EX-31.2 - EX-31.2 - Tobira Therapeutics, Inc. | tbra-ex312_8.htm |
| EX-31.1 - EX-31.1 - Tobira Therapeutics, Inc. | tbra-ex311_6.htm |
| 10-Q - 10-Q - Tobira Therapeutics, Inc. | tbra-10q_20160331.htm |
| EX-10.1 - EX-10.1 - Tobira Therapeutics, Inc. | tbra-ex101_549.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Tobira Therapeutics, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher Peetz, the Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
2. |
Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
|
|
/s/ Christopher Peetz |
|
May 9, 2016 |
|
Christopher Peetz |
|
|
|
Chief Financial Officer |
|
|
|
(Principal Financial Officer) |
A signed original of this written statement required by Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350), has been provided to Tobira Therapeutics, Inc. and will be retained by Tobira Therapeutics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Tobira Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.